Remove tag pulmonary-arterial-hypertension
article thumbnail

PharmaShots Weekly Snapshots (May 29 - June 02, 2023)

PharmaShots

Impact Therapeutics Entered into a License and Collaboration Agreement with Eikon Therapeutics to Develop and Commercialize IMP1734 Date: June 02, 2023 | Tags: Impact Therapeutics, Eikon Therapeutics, IMP1734, Pharma, China, Hong Kong, Macau, Taiwan BMS’ Mavacamten Receives the NICE Recommendation for the Treatment of Obstructive Hypertrophic (..)

FDA 40
article thumbnail

PharmaShots Weekly Snapshots (March 06 - 10, 2023)

PharmaShots

Vertex Receives the US FDA’s IND Clearance of VX-264 for the Treatment of Type 1 Diabetes Date: Mar 10, 2023 | Tags: Vertex, VX-264, Type 1 Diabetes, Regulatory, US, FDA, IND Alnylam Expands its Collaboration with Medison Pharma to Commercialize RNAi Therapies Date: Mar 10, 2023 | Tags: Alnylam, Medison Pharma, RNAi Therapies, Onpattro, patisiran, (..)

FDA 40
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Viagra ‘should be tested as Alzheimer’s therapy’

pharmaphorum

Sildenafil is also sold as Revatio to treat pulmonary artery hypertension (PAH). Viagra (sildenafil) – originally developed by Pfizer – is now widely available as a generic and can even be bought from pharmacies over-the-counter in some countries.

article thumbnail

A history of Johnson & Johnson

pharmaphorum

Later, another of J&J’s companies, Cordis Corporation, introduced the first drug-eluting stent, which helped prevent the arteries from re-clogging. For all the latest pharma news on Johnson & Johnson, follow pharmaphorum’s J&J and Janssen tags. CEO Alex Gorsky, who was appointed in 2012.

Vaccines 116